If you have listened to any/all of our #ASCO23 series with The Fellow On Call, please help us out by taking our brief survey 🫶🏼: redcap.vanderbilt.edu/surveys/?s=EE4…

We will be back with our regular TwoOncDocs content next Monday! #meded #hemonc

Friends! Help us continue to help you!

Did you check out our recent collab w/ TwoOncDocs about how to critically appraise abstracts from #ASCO23 ? If you listened to any/all of our ep., please fill out our brief survey: redcap.vanderbilt.edu/surveys/?s=EE4…

Ep. list: thefellowoncall.com/accolades/tfoc…

It’s been so fun teaming up with Karine Tawagi MD and Samantha Armstrong from TwoOncDocs for this special series! Can’t wait for more collabs in the future with you!

Vivek Patel, MD Daniel Hausrath

Ep. 5 and final (😭) ep. of our collab with our friends TwoOncDocs is now available! Here we talk about early stage ER+ breast ca, the NATALEE Trial presented at #ASCO23 , and 'interim analyses'! Check it out: podcasts.apple.com/us/podcast/upd…

What did y'all think of our series!?

Ep. 4 of our collab with our friends TwoOncDocs is now available! Here, we chat about NSCLC, the KEYNOTE 671 presented at #ASCO23 , 'multiplicity' and 'interaction tests'! Check it out here: podcasts.apple.com/us/podcast/epi…

What do you think of our series so far? Let us know!

Maybe I’m biased, but what sets our collab series apart from other #ASCO23 recaps is that we discuss abstracts, AND, arguably more importantly, Vivek Patel, MD drops biostats pearls in each ep.

And let’s be real, we can always use a stats refresher. So imp. regardless of speciality.

Ep. 2 of our collab with our friends TwoOncDocs is now available! This time, we talk about the SWOG 1826 plenary from #ASCO23 , define p-values, trial medians, the pros/cons of the trial & how this informs our mgmt of Hodgkin's lymphoma! Check it out here: podcasts.apple.com/us/podcast/the…

Episode 1 of our collab with our friends TwoOncDocs is now available! We talk all about the #PROSPECT Trial discussed at #ASCO23 , what a 'non-inferiority trial' really is, pros/cons of the study, & how this informs our mgmt! Check it out here: podcasts.apple.com/us/podcast/two…

Follow along with Samantha Armstrong and Karine Tawagi MD of TwoOncDocs as they show you a #dayinthelife of an ASCO member at #ASCO23 !

Won’t deny that Maria Antonia Velez and I fangirl-ed a bit when meeting TwoOncDocs at this year’s #ASCO2023 . They are as as wonderful in person as they seem! Thanks for all the board review!

#ASCO23 was vibrant, inspiring & FUN! Grateful for the fantastic colleagues & members I work w—most of who I only saw in passing!

Honorable mention to the Adidas Stan Smiths for 30+ mi of steps in total comfort 👟 🙌
Amanda Narod Narjust Florez, M.D. Karine Tawagi MD Samantha Armstrong

#ASCO23 Plenary session underway with results of the PROSPECT trial

🎗️Compared neoadjuvant CRT vs FOLFOX
🎗️ Non-inferiority DFS was met
🎗️Path CR and QOL similar
🎗️Neoadjuvant FOLFOX, with selective use CRT, is an effective tx for pts with CT2N+, cT3N-, or cT3N+ rectal cancer

#sarcoma docs don’t back down from challenging clinical scenarios.
Is it hard to give adults with #osteosarcoma HDMTX? Yes! Should we just skip it bc it’s hard? No!
Katie Janeway Richard Riedel

Combination chemo plus IO:

DOX 75 mg/m2/d on D1 followed by DAC 400 mg/m2/d on D1 & 2, plus NIV 360 mg on D2 after DAC Q3W, followed by 1-year NIV maintenance is a feasible and well-tolerated in patients with #leiomyosarcoma #sarcoma #ASCO23 OncoAlert

🇨🇦, featured voices & med ed unite Oncology Brothers x TwoOncDocs #ASCO23

PRODIGE23 TNT continues to show long term benefit in all survival endpoints over SOC. Now the question is how to best do it… which patients really need FOLFIRINOX? #ASCO23 #crcsm

Rise and Shine #ASCO23 🌞

Don’t forget to stop by Career Connections located in Hall C (North Building, Level 2) for the career fair and free professional headshots 📸

The ultimate #hemeonc #meded mashup at #ASCO23 🎉🎉🎉🎉

Did you even go to #ASCO23 if you didn’t get a selfie latte 🙃

We LOVED the session on creating a memorable presentation

Key Takeaways:
📚 Learners remember start and end of talk
📚Work through a problem beforehand
📚 Summarize key points
📚Set reasonable time, not too long

The last two concepts are very familiar to us 😉 #ASCO23 #MedEd